Search for: "SAM v. SAM"
Results 21 - 40
of 2,155
Sort by Relevance
|
Sort by Date
7 Aug 2024, 10:09 am
The most recent instance is ASTM v. [read post]
7 Aug 2024, 1:30 am
On 12 July 2024 the English Court of Appeal gave its second FRAND determination judgment, in the context of an appeal and cross-appeal of Mellor J’s first instance decision in IDC v Lenovo. [read post]
6 Aug 2024, 9:39 am
I previously wrote (including here and here) about a suit Elon Musk filed against Sam Altman and OpenAI; in large part, he claimed that Altman had converted OpenAI from a nonprofit to a for-profit, in violation of its early plans.... [read post]
6 Aug 2024, 8:12 am
” State v. [read post]
31 Jul 2024, 3:00 am
On 19 July 2024, the Court of Appeal handed down its judgment in Comptroller – General of Patents, Designs and Trade Marks v Emotional Perception AI Limited [2024] EWCA Civ 825 following a hearing on 14-15 May 2024. [read post]
31 Jul 2024, 1:14 am
Dr. [read post]
29 Jul 2024, 7:51 pm
Alito, who had authored the 2022 decision in Dobbs v. [read post]
29 Jul 2024, 10:21 am
Two take two of his examples: Chief Justice Roberts's infamous vote and opinion in NFIB v. [read post]
29 Jul 2024, 9:17 am
In the second case, Panasonic v. [read post]
29 Jul 2024, 2:16 am
Edward, Reconsidering the Legacy of New York Times V. [read post]
26 Jul 2024, 3:00 am
The Court of Appeal was clear, in the earlier case of Vestel v Access Advance [2021] EWCA Civ 440, that it is impermissible under English law to bring a free-standing claim for declaratory relief in relation to a FRAND licence. [read post]
24 Jul 2024, 4:35 am
This contrasts with the US revocation, based on enablement requirement, and where enablement was judged insufficient because, even from the description, the skilled person had to make an inventive effort to arrive at the millions of antibodies covered, according to the Supreme Court, by Amgen patents (21-757 Amgen Inc. v. [read post]
24 Jul 2024, 4:35 am
This contrasts with the US revocation, based on enablement requirement, and where enablement was judged insufficient because, even from the description, the skilled person had to make an inventive effort to arrive at the millions of antibodies covered, according to the Supreme Court, by Amgen patents (21-757 Amgen Inc. v. [read post]
22 Jul 2024, 11:26 am
”[7] The Supreme Court’s 2019 decision in Fourth Estate v. [read post]
22 Jul 2024, 12:07 am
According to the CD Munich, the skilled person does not see Figure 26 as the (sole) definition of the catalytic domain in P4 or the Patent, see reason 7.11: Rather Figure 26, whilst keeping consistent with the understanding of the pro-, catalytic and V-domains as follows from P3, shows a sequence comparison of the PCSK9 amino acid sequence (“PCSK9parent”) and residues that were mutated in certain PCSK9 variants (“PCSK9mutants”). [read post]
18 Jul 2024, 2:35 am
Ortovox v Mammut The UPC also considered the role of protective letters in Ortovox Sportartikel GmbH v Mammut Sports Group AG, Mammut Sports Group GmbH (“Ortovox v Mammut”). [read post]
11 Jul 2024, 3:31 am
Granted, it comes on the heels of Loper Bright and Trump v. [read post]
10 Jul 2024, 9:01 pm
And time and again, those courts determined that the transactions at issue—ranging from investment opportunities in oil barrels to fishing boats to silver foxes—did in fact constitute the offer or sale of securities.[8] And then in 1946, the Supreme Court issued its seminal opinion in SEC v. [read post]
10 Jul 2024, 9:01 am
The court order issued in Associated General Contractors v. [read post]
9 Jul 2024, 4:10 am
This follows his earlier judgment in Teva v Novartis ([2022] EWHC 2847 (Pat)). [read post]
